The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

ERC Synergy Grant for the development of custom-made stem cell therapies for neurodegenerative disorders

Malin Parmar. Photo.
“Our goal is to make advances in stem cell therapy by modifying and adapting cells to the patient’s needs", explains Malin Parmar. Photo: Tove Smeds

Malin Parmar, professor of cellular neuroscience leading one of MultiPark's research groups, along with three researchers in Italy and Denmark, has been awarded the prestigious ERC Synergy Grant worth EUR 10 million. The four researchers aim to develop custom-made neurons from stem cells for cell therapies to treat Parkinson’s or Huntington’s disease.

“We want to develop a completely new concept in stem cell therapy. Every patient is different and therefore we want to develop ways to custom make cells and stem cell therapies for neurodegenerative diseases. Our focus in the project is on Parkinson’s disease and Huntington’s disease,” says Malin Parmar.

Read more about this project here.